Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Genitourinary 1Endocrine 1CNS 1

Conditions

Thyroid Neoplasms 1Sarcoma 1Pheochromocytoma 1Paraganglioma 1Neoplastic Syndromes, Hereditary 1Melanoma 1Kidney Neoplasms 1Hematologic Neoplasms 1Glioma 1Bone Neoplasms 1

Interventions

pembrolizumab 2belinostat 2Surveys and Questionnaires 2Radiosurgery 2Nivolumab 2Magnetic Resonance Spectroscopy 2Cisplatin 2trastuzumab deruxtecan 1trametinib 1tislelizumab 1tipifarnib 1temsirolimus 1spartalizumab 1selpercatinib 1romidepsin 1repotrectinib 1regorafenib 1pazopanib 1larotrectinib 1durvalumab 1cemiplimab 1cc-486 1alectinib 1Valproic Acid 1Transurethral Resection of Prostate 1Tamoxifen 1Sunitinib 1Specimen Handling 1Sirolimus 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Genetic Testing × Sarcoma × Clear all
NCT03160274 2025-10-15

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

The University of Texas Health Science Center at San Antonio

Recruiting
2,000 enrolled
CNSEndocrineGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡